Annual Meeting News

LANSING, Mich.--(BUSINESS WIRE)--Neogen Corporation (NASDAQ: NEOG) today hosted its 2026 Investor Day, "Shaping the Future of Food Safety," in New York City, where the company's senior leadership team outlined a comprehensive strategy for sustained profitable growth and category leadership, and provided a framework under which it plans to achieve financial targets by fiscal year 2031. The event featured presentations from Mike Nassif, President and Chief Executive Officer; Bryan Riggsbee, Chief...

VILLEJUIF, France--(BUSINESS WIRE)--Regulatory News: Valerio Therapeutics (FR0010095596 - ALVIO), a pioneering biotechnology company in the field of next-generation precision therapies (“Valerio”, or the “Company”), provides an update on its operations and presents its financial results for the half-year ended 30 June 2026. “The first half of 2026 marked a decisive milestone in the consolidation of our strategic refocusing and in the transformation of Valerio Therapeutics. The operational launc...

CINCINNATI--(BUSINESS WIRE)--The Procter & Gamble Company (NYSE: PG) will webcast its 2026 Annual Meeting of Shareholders, held virtually via a live audio webcast on Tuesday, October 13, 2026, at 9:00 a.m. Eastern Time at: www.virtualshareholdermeeting.com/PG2026. Media and investors may access the live webcast beginning at 8:45 a.m., approximately 15 minutes before the annual meeting’s 9:00 a.m. start time. The webcast will also be available for replay. For information on meeting business...

ATLANTA--(BUSINESS WIRE)--The Annual Meeting of the HOPE Global Forums, the world’s largest gathering dedicated to economic inclusion, financial literacy and the empowerment of underserved communities, will take place December 2-3, 2026 at the Signia by Hilton in downtown, marking the 12th year that Operation HOPE’s flagship global gathering will be held in Atlanta. Atlanta Mayor Andre Dickens will return as Co-Chair of the event, continuing a longstanding partnership between Operation HOPE and...

VANCOUVER, B.C.--(BUSINESS WIRE)--Spanish Mountain Gold Ltd. (the "Company" or "Spanish Mountain Gold") (TSX-V: SPA) (FSE: S3Y) (OTCQB: SPAUF) is pleased to announce the voting results from its 2026 Annual General Meeting held in Vancouver, British Columbia, on October 1, 2026 (the “AGM”). At the AGM, a total of 123,703,643 common shares were voted, representing 23.41% of the outstanding common shares as of the record date. Shareholders elected the following directors at the AGM: Brent Bergeron...

MINNETONKA, Minn. & REHOVOT, Israel--(BUSINESS WIRE)--Stratasys Ltd. (Nasdaq: SSYS) (“Stratasys” or the “Company”) today announced that it will hold its 2026 Annual General Meeting of Shareholders (the “Meeting”) on Tuesday, November 10, 2026, at 3:00 p.m. Israel time, at Meitar Law Offices, 1 Ariel Sharon Street, 36th floor, Givatayim 5320048, Israel. The record date for shareholders entitled to vote at the Meeting is Friday, October 9, 2026.The agenda for the Meeting is as follows:Re-election...

NOME, Alaska--(BUSINESS WIRE)--The Alaska Permanent Fund Corporation's (APFC) Board of Trustees convened its Annual Meeting on September 30 and October 1, 2026, in Nome and online. Trustees reviewed Fiscal Year (FY) 2026 Fund performance, received an in-depth review of the Real Estate portfolio, adopted an updated Investment Policy Statement, and established a Benchmark Review Committee. As part of its annual governance responsibilities, the Board also elected its corporate officers, reelecting...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Obsidian Therapeutics, Inc. (“Obsidian”) (Nasdaq: OBX), a clinical-stage biopharmaceutical company harnessing novel protein-regulation technology to develop engineered tumor-infiltrating lymphocyte (TIL) cell therapies, today announced a poster presentation of updated data in patients with immune-checkpoint inhibitor (ICI)-resistant advanced melanoma from the Phase 1 single-center first-in-human (FIH) study and the Phase 1/2 Agni-01 multicenter study of amsoki...

LARKSPUR, Calif.--(BUSINESS WIRE)--Aulos Bioscience, an immuno-oncology company working to revolutionize cancer care through development of its lead immune-activating antibody therapeutic imneskibart (AU-007), today announced that two presentations of new data from its ongoing Phase 1/2 study of imneskibart will be featured at the Society for Immunotherapy of Cancer (SITC) Annual Meeting. One presentation will focus on promising Phase 2 results for imneskibart with avelumab in checkpoint inhibi...

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Pheast Therapeutics, a clinical-stage biotechnology company advancing next-generation targeted therapies for cancer, today announced an upcoming poster presentation of preclinical data on PHST001 at the 41st Society for Immunotherapy of Cancer (SITC) Annual Meeting, taking place from November 4-8 in Phoenix, AZ. PHST001 is a first-in-class anti-CD24 macrophage checkpoint inhibitor designed to restore immune recognition in the tumor microenvironment and is c...